Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
11.8M
-
Shares change
-
-1.59M
-
Total reported value, excl. options
-
$38.4M
-
Value change
-
-$5.17M
-
Put/Call ratio
-
0.95
-
Number of buys
-
26
-
Number of sells
-
-37
-
Price
-
$3.26
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2022
84 filings reported holding HUMA - Humacyte, Inc. - COM as of Q3 2022.
Humacyte, Inc. - COM (HUMA) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.8M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.67M shares), BlackRock Inc. (2.21M shares), York Capital Management Global Advisors, LLC (1.4M shares), GEODE CAPITAL MANAGEMENT, LLC (682K shares), UBS OCONNOR LLC (595K shares), Prescott General Partners LLC (568K shares), MILLENNIUM MANAGEMENT LLC (424K shares), STATE STREET CORP (419K shares), LPL Financial LLC (313K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (304K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.